| pubmed-article:2412783 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C0000589 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C0445223 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C1552599 | lld:lifeskim |
| pubmed-article:2412783 | lifeskim:mentions | umls-concept:C1704787 | lld:lifeskim |
| pubmed-article:2412783 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2412783 | pubmed:dateCreated | 1985-11-12 | lld:pubmed |
| pubmed-article:2412783 | pubmed:abstractText | A considerable blastomogenic effect of metabolite serotonin 5-methoxytryptamine (5-MOT) subcutaneously administered for a long time to C57BL/6 mice was established. This effect was decreased noticeably if the further metabolism of 5-MOT into 5-methoxyindolyl-3-acetic acid (5-MIAA) was blocked by pyrazidol. These results explain the fact that the blastomogenic effect of 5-MOT is not direct but is caused by the transformation of 5-MOT into its final carcinogenic metabolite 5-MIAA. | lld:pubmed |
| pubmed-article:2412783 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2412783 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2412783 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2412783 | pubmed:issn | 0204-3564 | lld:pubmed |
| pubmed-article:2412783 | pubmed:author | pubmed-author:RaushenbakhM... | lld:pubmed |
| pubmed-article:2412783 | pubmed:author | pubmed-author:SergeevaT ITI | lld:pubmed |
| pubmed-article:2412783 | pubmed:author | pubmed-author:RomanenkoV... | lld:pubmed |
| pubmed-article:2412783 | pubmed:author | pubmed-author:AndreevaN INI | lld:pubmed |
| pubmed-article:2412783 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2412783 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:2412783 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2412783 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2412783 | pubmed:pagination | 26-9 | lld:pubmed |
| pubmed-article:2412783 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:meshHeading | pubmed-meshheading:2412783-... | lld:pubmed |
| pubmed-article:2412783 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:2412783 | pubmed:articleTitle | [Carcinogenic action of 5-methoxytryptamine related to its transformation into 5-methoxyindolyl-3-acetic acid]. | lld:pubmed |
| pubmed-article:2412783 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2412783 | pubmed:publicationType | English Abstract | lld:pubmed |
